
Protagonist Therapeutics Inc
NASDAQ:PTGX

Intrinsic Value
The intrinsic value of one
PTGX
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 55.68 USD,
Protagonist Therapeutics Inc
is
hidden
.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Protagonist Therapeutics Inc
PTGX looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether PTGX usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Fundamental Analysis


Revenue & Expenses Breakdown
Protagonist Therapeutics Inc
Balance Sheet Decomposition
Protagonist Therapeutics Inc
Current Assets | 605.9m |
Cash & Short-Term Investments | 574.4m |
Receivables | 27.1m |
Other Current Assets | 4.4m |
Non-Current Assets | 136.3m |
Long-Term Investments | 123.5m |
PP&E | 12.5m |
Other Non-Current Assets | 225k |
Free Cash Flow Analysis
Protagonist Therapeutics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Protagonist Therapeutics Inc
Revenue
|
207.8m
USD
|
Operating Expenses
|
-180.6m
USD
|
Operating Income
|
27.2m
USD
|
Other Expenses
|
29m
USD
|
Net Income
|
56.2m
USD
|
PTGX Profitability Score
Profitability Due Diligence
Protagonist Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Score
Protagonist Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
PTGX Solvency Score
Solvency Due Diligence
Protagonist Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Score
Protagonist Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PTGX Price Targets Summary
Protagonist Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
PTGX
is 70.38 USD
with a low forecast of 41.41 USD and a high forecast of 86.1 USD.
Dividends
Current shareholder yield for PTGX is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
PTGX
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 55.68 USD,
Protagonist Therapeutics Inc
is
hidden
.